As of 2026-04-28, the Relative Valuation of Antares Pharma Inc (ATRS) is 5.85 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 4.7%.
The range of the Relative Valuation is 5.70 - 5.95 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 17.1x - 17.8x | 17.6x |
| Fair Price | 5.70 - 5.95 | 5.85 |
| Upside | 2.0% - 6.4% | 4.7% |
| Date | P/E |